Diabetes 54:482-491, 2005
© 2005 by the American Diabetes Association, Inc.
ß-Cell Pdx1 Expression Is Essential for the Glucoregulatory, Proliferative, and Cytoprotective Actions of Glucagon-Like Peptide-1
Yazhou Li1,
Xiemin Cao1,
Li-Xin Li2,
Patricia L. Brubaker1,2,
Helena Edlund3, and
Daniel J. Drucker1
1 Department of Medicine, University of Toronto, The Banting and Best Diabetes Centre, The Toronto General Hospital, University of Toronto, Toronto, Canada
2 Department of Physiology, University of Toronto, Toronto, Canada
3 Umea Centre for Molecular Medicine, Umea University, Umea, Sweden
Glucagon-like peptide-1 (GLP-1) regulates energy intake, gastrointestinal motility, and nutrient disposal. The relative importance of the islet ß-cell for GLP-1 actions remains unclear. We determined the role of the islet ß-cell and the pancreatic duodenal homeobox-1 (Pdx1) transcription factor for GLP-1 receptor (GLP-1R)-dependent actions through analysis of mice with ß-cell–specific inactivation of the Pdx1 gene (ß-cellPdx1–/– mice). The GLP-1R agonist exendin-4 (Ex-4) reduced glycemic excursion following intraperitoneal (i.p.) glucose challenge in control littermates (ß-cellPdx1+/+ mice) but not in ß-cellPdx1–/– mice. Similarly, Ex-4 failed to increase levels of plasma insulin, pancreatic insulin content, and pancreatic insulin mRNA transcripts in ß-cellPdx1–/– mice. Furthermore, Ex-4 significantly increased ß-cell proliferation and reduced ß-cell apoptosis in ß-cellPdx1+/+ mice but not in ß-cellPdx1–/– mice. Moreover, Ex-4 increased the levels of insulin and amylin mRNA transcripts and augmented glucose-stimulated insulin secretion in islets from ß-cellPdx1+/+ mice but not in ß-cellPdx1–/– islets. Surprisingly, Ex-4 failed to reduce levels of plasma glucagon in ß-cellPdx1–/– mice. These findings demonstrate that Pdx1 expression is essential for integrating GLP-1R–dependent signals regulating -cell glucagon secretion and for the growth, differentiated function, and survival of islet ß-cells.
Address correspondence and reprint requests to Dr. Daniel J. Drucker, Toronto General Hospital, BantingBest Diabetes Centre, 200 Elizabeth St., MBRW 4R402-2, Toronto, Canada M5G 2C4. E-mail: d.drucker{at}utoronto.ca

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Edfalk, P. Steneberg, and H. Edlund
Gpr40 Is Expressed in Enteroendocrine Cells and Mediates Free Fatty Acid Stimulation of Incretin Secretion
Diabetes,
September 1, 2008;
57(9):
2280 - 2287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-J. Song, W. E. Schreiber, E. Zhong, F.-F. Liu, B. D. Kornfeld, F. E. Wondisford, and M. A. Hussain
Exendin-4 Stimulation of Cyclin A2 in {beta}-Cell Proliferation
Diabetes,
September 1, 2008;
57(9):
2371 - 2381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Granata, F. Settanni, D. Gallo, L. Trovato, L. Biancone, V. Cantaluppi, R. Nano, M. Annunziata, P. Campiglia, E. Arnoletti, et al.
Obestatin Promotes Survival of Pancreatic {beta}-Cells and Human Islets and Induces Expression of Genes Involved in the Regulation of {beta}-Cell Mass and Function
Diabetes,
April 1, 2008;
57(4):
967 - 979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Keller, S. McWeeney, A. Arsenlis, J. Drouin, C. V. E. Wright, H. Wang, C. B. Wollheim, P. White, K. H. Kaestner, and R. H. Goodman
Characterization of Pancreatic Transcription Factor Pdx-1 Binding Sites Using Promoter Microarray and Serial Analysis of Chromatin Occupancy
J. Biol. Chem.,
November 2, 2007;
282(44):
32084 - 32092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Krishnamurthy, F. Ayazi, J. Li, A. W. Lyttle, M. Woods, Y. Wu, S.-P. Yee, and R. Wang
c-Kit in Early Onset of Diabetes: A Morphological and Functional Analysis of Pancreatic {beta}-Cells in c-KitW-v Mutant Mice
Endocrinology,
November 1, 2007;
148(11):
5520 - 5530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Holst
The Physiology of Glucagon-like Peptide 1
Physiol Rev,
October 1, 2007;
87(4):
1409 - 1439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Gromada, I. Franklin, and C. B. Wollheim
{alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Endocr. Rev.,
February 1, 2007;
28(1):
84 - 116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Maedler, D. M. Schumann, N. Sauter, H. Ellingsgaard, D. Bosco, R. Baertschiger, Y. Iwakura, J. Oberholzer, C. B. Wollheim, B. R. Gauthier, et al.
Low Concentration of Interleukin-1{beta} Induces FLICE-Inhibitory Protein-Mediated {beta}-Cell Proliferation in Human Pancreatic Islets.
Diabetes,
October 1, 2006;
55(10):
2713 - 2722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Maedler, D. M. Schumann, F. Schulthess, J. Oberholzer, D. Bosco, T. Berney, and M. Y. Donath
Aging Correlates With Decreased {beta}-Cell Proliferative Capacity and Enhanced Sensitivity to Apoptosis: A Potential Role for Fas and Pancreatic Duodenal Homeobox-1
Diabetes,
September 1, 2006;
55(9):
2455 - 2462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Kim, Y. T. Noh, M.-J. Ryu, H.-T. Kim, S.-E. Lee, C.-H. Kim, C. Lee, Y. H. Kim, and C. Y. Choi
Phosphorylation and Transactivation of Pax6 by Homeodomain-interacting Protein Kinase 2
J. Biol. Chem.,
March 17, 2006;
281(11):
7489 - 7497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. De Leon, C. Farzad, M. F. Crutchlow, J. Brestelli, J. Tobias, K. H. Kaestner, and D. A. Stoffers
Identification of transcriptional targets during pancreatic growth after partial pancreatectomy and exendin-4 treatment
Physiol Genomics,
January 12, 2006;
24(2):
133 - 143.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Diabetes Association.
|
|
| |
|